Report October 2009: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
'''Status of Scientific and Market Knowledge''' | '''Status of Scientific and Market Knowledge''' | ||
* Focusing on Genetic Diagnostics | * Focusing on Genetic Diagnostics | ||
* | ** started [[Data,_narratives_and_tools_produced_by_the_Kits'_sector| case studies of commercially available genetic diagnostics]] | ||
'''Status of Intellectual Property Knowledge''' | '''Status of Intellectual Property Knowledge''' | ||
'''Bibliography and Paper Organization''' | '''Bibliography and Paper Organization''' | ||
* Added and reviewed | * Added and reviewed new articles to the [[Diagnostic_Kits#Bibliography|bibliography]]. Some key reports: | ||
** SACGHS | ** [[Diagnostic_Kits/SACGHS_Gene_Patents_and_Licensing_Practices|Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)âPublic Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests]] | ||
** SACGHS | ** SACGHS Gene Patents Appendix 1 | ||
** | ** [[Diagnostic_Kits/The_dangers_of_diagnostic_monopolies | Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. The dangers of diagnostic monopolies. Nature, 458(7237), 405-406]] | ||
** | ** [Diagnostic_Kits/Patents_and_the_Progress_of_Personalized_Medicine | Herder, M., Patents & the Progress of Personalized Medicine: Biomarkers Research as Lens. SSRN eLibrary]] | ||
** [[Diagnostic_Kits/Legal_uncertainty_in_the_area_of_genetic_diagnostic_testing | Huys et al. Legal uncertainty in the area of genetic diagnostic testing. Nature Biotech (2009) vol. 27 (10) pp. 903-909]] | |||
=== Work Completed === | === Work Completed === | ||
Revision as of 15:41, 20 November 2009
Alternative Energy
Tasks Completed
- Uploaded the AE paper into the wiki
- Added all of the graphs and figures in the the paper
- Edited sections to include new AE findings and to update sections
- Added a new bibliography page and consolidated all sources
- Linked all citations to the new bibliography page and standardized them to conform to Harvard Reference Format.
- Added footnotes into the paper
Biotechnology: Diagnostic Kits
General Status
Status of Scientific and Market Knowledge
- Focusing on Genetic Diagnostics
Status of Intellectual Property Knowledge
Bibliography and Paper Organization
- Added and reviewed new articles to the bibliography. Some key reports:
- Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)âPublic Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests
- SACGHS Gene Patents Appendix 1
- Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. The dangers of diagnostic monopolies. Nature, 458(7237), 405-406
- [Diagnostic_Kits/Patents_and_the_Progress_of_Personalized_Medicine | Herder, M., Patents & the Progress of Personalized Medicine: Biomarkers Research as Lens. SSRN eLibrary]]
- Huys et al. Legal uncertainty in the area of genetic diagnostic testing. Nature Biotech (2009) vol. 27 (10) pp. 903-909
Work Completed
- case studies of commercially available genetic diagnostics
- Bibliography with Literature Review
- Blog Post 1
Work Partially Completed
- IP profile of the biggest for-profit companies in AE
- Overview of Economics of Intellectual Property in Kits
- IP in Kits
- IP Profile of Universities working in Kits
- Commons based cases in Kits
- Interviews with experts on diagnostic kits
- Give an overall picture of the Kits' sector
Work Remaining
- Data, narratives and tools produced by the Kits' sector
- Competitive advantages in Kits
- IP Profile of Biggest for-profit companies in Kits
- IP Profile of non-profit companies in Kits
- IP Profile of Associations in Kits
- Peer-Production Business models in Kits
- Open Business models in Kits
Research Methodology in use
- Case studies
- Literature review
- Government Reports
Problems and Considerations
See Diagnostic_Kits/The_Argument_Framework#Outstanding_Questions